SCHEMBL16112722

SCHEMBL16112722

CCCCOC(=O)N1CCN(c2ccc(-c3cnc4c(Br)cnn4c3)cc2C#N)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RET P07949 15/20 0.44
BMPR1B O00238 2/20 0.42
BMPR1A P36894 2/20 0.42
ACVR1B P36896 2/20 0.42
ACVRL1 P37023 2/20 0.42
ACVR1 Q04771 2/20 0.42
PLK4 O00444 1/20 0.41
AURKA O14965 1/20 0.41
DYRK3 O43781 1/20 0.41
MAP4K4 O95819 1/20 0.41
NTRK1 P04629 1/20 0.41
INSR P06213 1/20 0.41
CDK1 P06493 1/20 0.41
FGFR1 P11362 1/20 0.41
FLT1 P17948 1/20 0.41
CDK2 P24941 1/20 0.41
MARK3 P27448 1/20 0.41
FLT4 P35916 1/20 0.41
KDR P35968 1/20 0.41
FLT3 P36888 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16112382 0.89 PLK4 (0.43) RETBMPR1BBMPR1AACVR1BACVRL1
SCHEMBL16112298 0.89 MAPT (0.44) RETBMPR1BBMPR1AACVR1BACVRL1
SCHEMBL16112583 0.86 RET (0.57) RET
SCHEMBL16112667 0.78 CYP4F2 (0.54) BMPR1BBMPR1AACVR1BACVRL1ACVR1
SCHEMBL17531633 0.78 BMPR1A (0.52) RETBMPR1BBMPR1AACVR1BACVRL1
SCHEMBL16111712 0.74 RET (0.57) RETPLK4AURKADYRK3MAP4K4
SCHEMBL16112600 0.74 PLK4 (0.47) BMPR1BBMPR1AACVR1BACVRL1ACVR1
SCHEMBL16134907 0.74 RET (0.56) RETBMPR1AACVR1BACVRL1ACVR1
SCHEMBL19611343 0.73 BMPR1B (0.42) RETBMPR1BBMPR1AACVR1BACVRL1
SCHEMBL16112423 0.70 RET (0.56) RET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2970311-A2 BMP INHIBITORS AND METHODS OF USE THEREOF The Brigham and Women's Hospital, Inc. (US) 2016-01-20 EP disclosed
WO-2014160203-A2 BMP INHIBITORS AND METHODS OF USE THEREOF THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) 2014-10-02 WO disclosed